Canada · Health Canada Drug Product Database

NAPROXEN

Source ingredient · 91 source records

Names are grouped within this source and country. A shared ingredient does not establish interchangeable medicines.

Canada · Source reference 4981

APO NAPROXEN TAB 125MG

Tablet / APOTEX INC

Canada · Source reference 4980

APO-NAPROXEN

Tablet / APOTEX INC

Canada · Source reference 5222

APO-NAPROXEN

Tablet / APOTEX INC

Canada · Source reference 5508

APO-NAPROXEN

Tablet / APOTEX INC

Canada · Source reference 106722

APO-NAPROXEN / ESOMEPRAZOLE

Tablet (Immediate- And Delayed-Release) / APOTEX INC

Canada · Source reference 106723

APO-NAPROXEN / ESOMEPRAZOLE

Tablet (Immediate- And Delayed-Release) / APOTEX INC

Canada · Source reference 70895

APO-NAPROXEN EC

Tablet (Enteric-Coated) / APOTEX INC

Canada · Source reference 70896

APO-NAPROXEN EC

Tablet (Enteric-Coated) / APOTEX INC

Canada · Source reference 70894

APO-NAPROXEN EC TABLETS

Tablet (Enteric-Coated) / APOTEX INC

Canada · Source reference 44216

APO-NAPROXEN SR TABLETS 750MG

Tablet (Extended-Release) / APOTEX INC

Canada · Source reference 85072

AVA-NAPROXEN EC

Tablet (Enteric-Coated) / AVANSTRA INC

Canada · Source reference 85074

AVA-NAPROXEN EC

Tablet (Enteric-Coated) / AVANSTRA INC

Canada · Source reference 107084

JAMP NAPROXEN

Tablet / JAMP PHARMA CORPORATION

Canada · Source reference 107085

JAMP NAPROXEN

Tablet / JAMP PHARMA CORPORATION

Canada · Source reference 107086

JAMP NAPROXEN

Tablet / JAMP PHARMA CORPORATION

Canada · Source reference 64618

MYLAN-NAPROXEN EC

Tablet (Enteric-Coated) / MYLAN PHARMACEUTICALS ULC

Canada · Source reference 67340

MYLAN-NAPROXEN EC

Tablet (Enteric-Coated) / MYLAN PHARMACEUTICALS ULC

Canada · Source reference 67341

MYLAN-NAPROXEN EC

Tablet (Enteric-Coated) / MYLAN PHARMACEUTICALS ULC

Canada · Source reference 92813

MYLAN-NAPROXEN/ESOMEPRAZOLE MR

Tablet (Immediate- And Delayed-Release) / MYLAN PHARMACEUTICALS ULC

Canada · Source reference 94575

MYLAN-NAPROXEN/ESOMEPRAZOLE MR

Tablet (Immediate- And Delayed-Release) / MYLAN PHARMACEUTICALS ULC

Canada · Source reference 19314

NAPROSYN

Tablet (Extended-Release) / SEARCHLIGHT PHARMA INC

Canada · Source reference 19315

NAPROSYN

Tablet (Delayed-Release) / SEARCHLIGHT PHARMA INC

Canada · Source reference 19316

NAPROSYN

Tablet (Delayed-Release) / SEARCHLIGHT PHARMA INC

Canada · Source reference 2346

NAPROSYN 250MG

Tablet / SYNTEX INC.

Canada · Source reference 19445

NAPROSYN 250MG TABLETS

Tablet / HOFFMANN-LA ROCHE LIMITED

Canada · Source reference 5279

NAPROSYN 375MG

Tablet / SYNTEX INC.

Canada · Source reference 19660

NAPROSYN 375MG TABLETS

Tablet / HOFFMANN-LA ROCHE LIMITED

Canada · Source reference 20123

NAPROSYN 500 MG SUPPOSITORIES

Suppository / HOFFMANN-LA ROCHE LIMITED

Canada · Source reference 19696

NAPROSYN 500 MG TABLETS

Tablet / HOFFMANN-LA ROCHE LIMITED

Canada · Source reference 19448

NAPROSYN E 250MG TABLETS - ECT

Tablet (Enteric-Coated) / HOFFMANN-LA ROCHE LIMITED

Browse ingredients in Canada
NAPROXEN | Molindra Medicines